Name: Elixinol Wellness (EXL) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

EXL

Household & Personal Products

Elixinol Wellness

Short interest: 0.04%; 0.00 pp 30d; as of 28 June 2023
Reported shorts: 190.9K
Shares on issue: 456.991M

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

About Elixinol Wellness

Elixinol Wellness Limited (ASX: EXL) is an Australian publicly listed company that pioneers in the global hemp industry, innovating, marketing, and selling hemp and other plant-derived nutraceutical, cosmetic, and food products. The company operates as a global leader in creating clean and healthy products and ingredients, owning a portfolio of wellness brands including Hemp Foods Australia, Mt Elephant, The Healthy Chef, and The Australian Superfood Co. From its Melbourne corporate office, EXL provides strategic oversight and governance, offering nutritious ingredients, finished consumer goods, and pet supplements to the Australian market, with a focus on sustainable agriculture practices.

Company profile →

Elixinol Wellness (ASX:EXL) has 0.04% of its shares on issue reported as short positions as of 28 June 2023, or about 190,931 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 2.46% in December 2019. EXL is classified in the Household & Personal Products industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Short interest

History & FAQ →

Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.

Strategy fit

How each stock picker strategy reads EXL today

Zanger BreakoutWatchScore 19rank 1206 of 1893
CAN SLIMNot a candidate
Minervini Trend TemplateNot a candidate
Crowded-Short BreakoutWatchScore 11rank 820 of 1448
Quality compoundersWatchScore 7rank 1561 of 1660

Prices to 15 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →

EXL fundamentals

In the half year to 30 Jun 2026, Elixinol Wellness (ASX:EXL) recorded revenue of A$7.8M and a net loss after tax of A$1.1M. Year-on-year growth: revenue +3.6% (FY). Net margin −35.5%, return on equity −62.9% (FY). Figures are in AUD, the company's reporting currency; source: Company filing (extracted) and Yahoo Finance, as at 11 Oct 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Full financials →